Topics Covered
We invite you to learn more about:
- CML research in search for a cure
- Emerging therapies for CML
- Treatment free remission
- Improving quality of life for patients
Program Materials
/sites/default/files/2022-09/slides_cml_9.28.22.pdf
/sites/default/files/2022-11/transcript_cml_9.28.22.pdf
Speakers
Ehab Atallah, MD
Professor, Medicine
Section Head, Hematologic Malignancies
Hematology and Oncology
Medical College of Wisconsin
Milwaukee, WI
Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program
Member, Memorial Sloan Kettering
Cancer Center
Professor, Weill Cornell Medicine
New York, NY
Kendra Sweet, MD, MS
Associate Member
Medical Director, Clinical Research
Malignant Hematology Department
Moffitt Cancer Center
Tampa, FL
Program Support
Support for this program is provided by Bristol Myers Squibb, Novartis, and Takeda Oncology